Table 3.
Outcomes at 90 d, Comparing the No‐Testing and Testing Groups
| No Testing | Testing | Adjusted HR (95% CI) | P Value | |
|---|---|---|---|---|
| Overall | ||||
| Cardiovascular death, MI | 281 (0.29) | 329 (0.34) | 1.17 (1.00–1.37) | 0.05 |
| Cardiovascular death | 87 (0.09) | 37 (0.04) | 0.43 (0.29–0.63) | <0.01 |
| MI | 205 (0.21) | 296 (0.31) | 1.45 (1.21–1.73) | <0.01 |
| High risk | ||||
| Cardiovascular death, MI | 73 (1.18) | 69 (1.12) | 0.95 (0.68–1.31) | 0.74 |
| Cardiovascular death | 30 (0.49) | 13 (0.21) | 0.43 (0.23–0.83) | <0.01 |
| MI | 45 (0.73) | 57 (0.92) | 1.27 (0.86–1.88) | 0.23 |
| Intermediate risk | ||||
| Cardiovascular death, MI | 172 (0.28) | 203 (0.33) | 1.18 (0.96–1.45) | 0.11 |
| Cardiovascular death | 48 (0.08) | 19 (0.03) | 0.40 (0.23–0.67) | <0.01 |
| MI | 132 (0.21) | 187 (0.30) | 1.42 (1.13–1.77) | <0.01 |
| Low risk | ||||
| Cardiovascular death, MI | 36 (0.13) | 57 (0.20) | 1.58 (1.04–2.41) | 0.03 |
| Cardiovascular death | 9 (0.03) | ≤5* | 0.56 (0.19–1.66) | 0.29 |
| MI | 28 (0.10) | ≥50* | 1.86 (1.17–2.94) | <0.01 |
Values are expressed as number (percentage) unless otherwise indicated. HR indicates hazard ratio.
Due to reidentification risk, ICES prohibits publication of cell sizes of <6.
Risk stratification: high risk: prior myocardial infarction (MI), unstable angina, or a revascularization procedure (percutaneous coronary intervention or coronary artery bypass grafting); intermediate risk: ≥1 cardiovascular risk factors (eg, dyslipidemia, diabetes mellitus, or hypertension); low risk: no cardiovascular risk factors.